Reply to comment on "Prevalence, risk factors, and management of adult asthma in Taipei, Taiwan: A global asthma network study" [0.03%]
关于“台湾台北成人哮喘患病率、危险因素和治疗状况的全球哮喘研究”一文的回复
Jui-Che Tsai,Kuo-Wei Yeh,Dah-Chin Yan et al.
Jui-Che Tsai et al.
Comment on 'Automated detection of marginal bone loss levels in implant brands using deep learning on periapical radiographs' [0.03%]
关于“使用深度学习在根尖片上自动检测种植体品牌边缘骨水平丢失”的评论
Yue Peng,Wenjuan Zhang
Yue Peng
Beyond baseline prediction: clinical considerations for sarculator validation in Asian extremity soft-tissue sarcoma [0.03%]
超越基线预测：亚洲四肢软组织肉瘤萨克拉tor验证的临床考虑因素
Xueying Ye,Yunfeng Hu
Xueying Ye
Comment on: "Evolution of COVID-19 antiviral interventions in Taiwan, 2022-2025: Insights from public health policy" [0.03%]
对“台湾COVID-19抗病毒干预措施的演变（2022-2025年）：公共卫生政策的启示”的评论
Chengzi Yao,Zhiqiang Jia,Li Tang
Chengzi Yao
Response to comment on "Early prompt response to COVID-19 in Taiwan: comprehensive surveillance, decisive border control, and information technology support" [0.03%]
对《台湾早期快速应对新冠肺炎疫情：全面监测、果断的边境管控和信息技术支持》一文的回应
Hao-Yuan Cheng,Ding-Ping Liu
Hao-Yuan Cheng
Authors' reply to "The unmeasured role of concomitant medication dynamics and immortal time bias in SGLT2 inhibitors study" [0.03%]
对来信《未测量的伴随药物变化作用及SGLT2抑制剂研究中的不朽时间偏倚》的回复
Chun-Ying Lee,Tzu-Jung Fang,Yun-Shiuan Chuang
Chun-Ying Lee
Comment on "Real-time endoscopic features to guide biopsy site selection for Helicobacter pylori detection": interpreting H&E-negative site biopsies [0.03%]
关于“用于检测幽门螺杆菌的实时内镜特征引导活检部位选择”的评论：解释H&E阴性位点活检结果
Mingyang Wang,Xiaoyu Yang,Li Yang
Mingyang Wang
Comment on "Predictors of online interactions with strangers in adolescents with and without attention-deficit/hyperactivity disorder: A prospective study" [0.03%]
评论：“注意缺陷多动障碍青少年与无注意缺陷多动障碍青少年在网上与陌生人互动的预测因素：一项前瞻性研究”
Huibin Luo,Jingwen Xiao,Shishuai Yuan et al.
Huibin Luo et al.